Invention Grant
- Patent Title: Engineered cells expressing anti-viral T cell receptors and methods of use thereof
-
Application No.: US17480697Application Date: 2021-09-21
-
Publication No.: US11421220B2Publication Date: 2022-08-23
- Inventor: Matthew James Spindler , David Scott Johnson , Ayla Lynn Nelson , Ellen Kathleen Wagner , Adam Shultz Adler , Yoong Wearn Lim , Michael Asensio
- Applicant: GigaMune, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: GigaMune, Inc.
- Current Assignee: GigaMune, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Fenwick & West LLP
- Main IPC: C40B30/04
- IPC: C40B30/04 ; C12N15/10 ; C07K14/725
Abstract:
Provided herein are compositions comprising recombinant mammalian cells that express recombinant T cell rectors with specificity against EBV or CMV peptide:MHC antigens. Also provided are therapeutic methods of using the recombinant mammalian cells as cell therapies against viral infections.
Public/Granted literature
- US20220002710A1 Engineered Cells Expressing Anti-Viral T Cell Receptors and Methods of Use Thereof Public/Granted day:2022-01-06
Information query
